150 related articles for article (PubMed ID: 27792402)
1. Is
De Crescenzo F; Ciliberto M; Menghini D; Treglia G; Ebmeier KP; Janiri L
Aging Ment Health; 2017 Sep; 21(9):889-894. PubMed ID: 27792402
[TBL] [Abstract][Full Text] [Related]
2. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.
Smith GS; Reynolds CF; Pollock B; Derbyshire S; Nofzinger E; Dew MA; Houck PR; Milko D; Meltzer CC; Kupfer DJ
Am J Psychiatry; 1999 May; 156(5):683-9. PubMed ID: 10327899
[TBL] [Abstract][Full Text] [Related]
3. Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression.
Wu JC; Gillin JC; Buchsbaum MS; Schachat C; Darnall LA; Keator DB; Fallon JH; Bunney WE
J Affect Disord; 2008 Apr; 107(1-3):181-6. PubMed ID: 18031825
[TBL] [Abstract][Full Text] [Related]
4. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study.
Smith GS; Reynolds CF; Houck PR; Dew MA; Ginsberg J; Ma Y; Mulsant BH; Pollock BG
Psychiatry Res; 2009 Jan; 171(1):1-9. PubMed ID: 19087899
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
Milak MS; Parsey RV; Lee L; Oquendo MA; Olvet DM; Eipper F; Malone K; Mann JJ
Psychiatry Res; 2009 Jul; 173(1):63-70. PubMed ID: 19446443
[TBL] [Abstract][Full Text] [Related]
6. Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
Guenther T; Schönknecht P; Becker G; Olbrich S; Sander C; Hesse S; Meyer PM; Luthardt J; Hegerl U; Sabri O
Neuroimage; 2011 May; 56(1):93-101. PubMed ID: 21276863
[TBL] [Abstract][Full Text] [Related]
7. Serotonin modulation of cerebral glucose metabolism in depressed older adults.
Smith GS; Kramer E; Hermann C; Ma Y; Dhawan V; Chaly T; Eidelberg D
Biol Psychiatry; 2009 Aug; 66(3):259-66. PubMed ID: 19368900
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.
Diaconescu AO; Kramer E; Hermann C; Ma Y; Dhawan V; Chaly T; Eidelberg D; McIntosh AR; Smith GS
Hum Brain Mapp; 2011 Oct; 32(10):1677-91. PubMed ID: 20886575
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.
Smith GS; Workman CI; Kramer E; Hermann CR; Ginsberg R; Ma Y; Dhawan V; Chaly T; Eidelberg D
Am J Geriatr Psychiatry; 2011 Jan; 19(1):53-63. PubMed ID: 21218565
[TBL] [Abstract][Full Text] [Related]
10. Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [
Liu J; Yu J; Liu HB; Yao Q; Zhang Y
Ann Nucl Med; 2022 Dec; 36(12):1019-1030. PubMed ID: 36178570
[TBL] [Abstract][Full Text] [Related]
11. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
[TBL] [Abstract][Full Text] [Related]
12. Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
Brendel M; Reinisch V; Kalinowski E; Levin J; Delker A; Därr S; Pogarell O; Förster S; Bartenstein P; Rominger A; Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2016; 13(5):475-86. PubMed ID: 26971944
[TBL] [Abstract][Full Text] [Related]
13. Effect of sleep deprivation on brain metabolism of depressed patients.
Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Johnson JC; Bunney WE
Am J Psychiatry; 1992 Apr; 149(4):538-43. PubMed ID: 1554042
[TBL] [Abstract][Full Text] [Related]
14. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.
Kennedy SH; Konarski JZ; Segal ZV; Lau MA; Bieling PJ; McIntyre RS; Mayberg HS
Am J Psychiatry; 2007 May; 164(5):778-88. PubMed ID: 17475737
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography with (18)F-FDG in the evaluation of patients with rheumatoid arthritis--a systematic review].
dos Anjos DA; da Mota LM
Rev Bras Reumatol; 2014; 54(6):474-82. PubMed ID: 25458029
[TBL] [Abstract][Full Text] [Related]
16.
Lyra V; Parissis J; Kallergi M; Rizos E; Filippatos G; Kremastinos D; Chatziioannou S
Eur J Heart Fail; 2020 Nov; 22(11):2138-2146. PubMed ID: 32530569
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [
Zhang HJ; Mitchell S; Fang YH; Tsai HM; Piao L; Ousta A; Leoni L; Chen CT; Sharp WW
Neurocrit Care; 2021 Feb; 34(1):64-72. PubMed ID: 32358767
[TBL] [Abstract][Full Text] [Related]
18. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
Kennedy SH; Evans KR; Krüger S; Mayberg HS; Meyer JH; McCann S; Arifuzzman AI; Houle S; Vaccarino FJ
Am J Psychiatry; 2001 Jun; 158(6):899-905. PubMed ID: 11384897
[TBL] [Abstract][Full Text] [Related]
19.
Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):220-224. PubMed ID: 32522411
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gallium-68 somatostatin receptor and
Liu X; Li N; Jiang T; Xu H; Ran Q; Shu Z; Wu J; Li Y; Zhou S; Zhang B
Hell J Nucl Med; 2020; 23(2):188-200. PubMed ID: 32716410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
